关注
Stefanie Hülsenbeck (geb. Dreger)
Stefanie Hülsenbeck (geb. Dreger)
Universitätsmedizin Mainz
在 unimedizin-mainz.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clostridium difficile toxins: more than mere inhibitors of Rho proteins
H Genth, SC Dreger, J Huelsenbeck, I Just
The international journal of biochemistry & cell biology 40 (4), 592-597, 2008
1462008
C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts
F Boato, S Hendrix, SC Huelsenbeck, F Hofmann, G Große, S Djalali, ...
Journal of cell science 123 (10), 1652-1662, 2010
1312010
The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity
C Henninger, J Huelsenbeck, S Huelsenbeck, S Grösch, A Schad, ...
Toxicology and applied pharmacology 261 (1), 66-73, 2012
962012
Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons
SC Huelsenbeck, A Schorr, WP Roos, J Huelsenbeck, C Henninger, ...
Journal of Biological Chemistry 287 (46), 38590-38599, 2012
912012
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin
C Henninger, S Huelsenbeck, P Wenzel, M Brand, J Huelsenbeck, ...
Pharmacological research 91, 47-56, 2015
832015
Difference in the Cytotoxic Effects of Toxin B from Clostridium difficile Strain VPI 10463 and Toxin B from Variant Clostridium difficile Strain 1470
J Huelsenbeck, S Dreger, R Gerhard, H Barth, I Just, H Genth
Infection and immunity 75 (2), 801-809, 2007
822007
Upregulation of the Immediate Early Gene Product RhoB by Exoenzyme C3 from Clostridium limosum and Toxin B from Clostridium difficile
J Huelsenbeck, SC Dreger, R Gerhard, G Fritz, I Just, H Genth
Biochemistry 46 (16), 4923-4931, 2007
592007
A 29‐amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation
M Höltje, S Djalali, F Hofmann, A Münster-Wandowski, S Hendrix, F Boato, ...
The FASEB Journal 23 (4), 1115-1126, 2009
582009
C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury
SC Huelsenbeck, A Rohrbeck, A Handreck, G Hellmich, E Kiaei, ...
Neurotherapeutics 9 (1), 185-198, 2012
422012
Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors—reinforcing the critical role of RhoA in cytokinesis
SC Huelsenbeck, M May, G Schmidt, H Genth
Cell motility and the cytoskeleton 66 (11), 967-975, 2009
332009
Killing of Rat Basophilic Leukemia Cells by Lethal Toxin from Clostridium sordellii: Critical Role of Phosphatidylinositide 3′-OH Kinase/Akt Signaling
SC Dreger, F Schulz, J Huelsenbeck, R Gerhard, F Hofmann, I Just, ...
Biochemistry 48 (8), 1785-1792, 2009
272009
Distinct kinetics of (H/K/N) Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin
SC Huelsenbeck, I Klose, M Reichenbach, J Huelsenbeck, H Genth
FEBS letters 583 (19), 3133-3139, 2009
242009
Therapeutic effects of Clostridium botulinum C3 exoenzyme
I Just, A Rohrbeck, SC Huelsenbeck, M Hoeltje
Naunyn-Schmiedeberg's archives of pharmacology 383, 247-252, 2011
222011
Clostridium botulinum C3 exoenzyme: Rho-inactivating tool in cell biology and a neurotrophic agent
I Just, SC Huelsenbeck, H Genth
The Open Toxinology Journal 3 (1), 2010
122010
Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1
SC Huelsenbeck, D Roggenkamp, M May, J Huelsenbeck, C Brakebusch, ...
The International Journal of Biochemistry & Cell Biology 45 (8), 1767-1775, 2013
52013
Rho-inhibiting toxins
I Just, SC Dreger, H Genth
Toxicology Letters 189, S18-S19, 2009
12009
Mentoring in der Hochschulmedizin
S Hülsenbeck
Praxishandbuch Mentoring in der Wissenschaft, 355-366, 2017
2017
Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury
G Ahnert-Hilger, G Groβe, F Hofmann, I Just, M Höltje, S Hülsenbeck
US Patent 8,747,841, 2014
2014
Cytoprotective activity of the small GTPase RhoB expressed upon treatment of fibroblasts with the E. coli cytotoxic necrotizing factor 1
H Genth, S Huelsenbeck, M May, D Roggenkamp, I Just, G Fritz, K Rottner, ...
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 386, S27-S27, 2013
2013
205 Evidence for Geno-and Cytoprotective Properties of Lipid Lowering Drugs (statins) in a BALB/c Mouse Model
C Henninger, J Huelsenbeck, SC Huelsenbeck, G Fritz
european journal of cancer, S50, 2012
2012
系统目前无法执行此操作,请稍后再试。
文章 1–20